International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA

Circulating tumoral DNA: Preanalytical validation and quality control in a diagnostic laboratory

(2018) Sergey Nikolaev et al.   ANALYTICAL BIOCHEMISTRY

Results of the first external quality assessment scheme (EQA) for isolation and analysis of circulating tumour DNA (ctDNA)

(2018) Verena Haselmann et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Integrating liquid biopsies into the management of cancer

(2017) Giulia Siravegna et al.   Nature Reviews Clinical Oncology

Review of the implementation of plasma ctDNA testing on behalf of IQN Path ASBL: a perspective from an EQA providers’ survey

(2017) Zandra C. Deans et al.   VIRCHOWS ARCHIV

The ins and outs of molecular pathology reporting

(2017) Véronique Tack et al.   VIRCHOWS ARCHIV

What's in a Name? A Coordinated Approach toward the Correct Use of a Uniform Nomenclature to Improve Patient Reports and Databases

(2016) Véronique Tack et al.   HUMAN MUTATION

Three Rounds of External Quality Assessment in France to Evaluate the Performance of 28 Platforms for Multiparametric Molecular Testing in Metastatic Colorectal and Non-Small Cell Lung Cancer

(2016) Elisabeth M.C. Dequeker et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Predictive and Prognostic Biomarkers in Non-Small Cell Lung Cancer

(2016) Shirish Gadgeel et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy

(2016) Cristiana Lo Nigro et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer

(2016) Nicola Normanno et al.   Oncotarget

EGFR mutations in lung cancer: from tissue testing to liquid biopsy

(2015) Francesca Fenizia et al.   Future Oncology

EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291

(2015) Kenneth S. Thress et al.   LUNG CANCER

Circulating tumor-derived DNA is shorter than somatic DNA in plasma

(2015) Florent Mouliere et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer

(2015) Karen Lise Garm Spindler et al.   PLoS One

Liquid Biopsies: Genotyping Circulating Tumor DNA

(2014) Luis A. Diaz et al.   JOURNAL OF CLINICAL ONCOLOGY

Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status

(2014) Jean-Yves Douillard et al.   Journal of Thoracic Oncology

Liquid biopsy: monitoring cancer-genetics in the blood

(2013) Emily Crowley et al.   Nature Reviews Clinical Oncology

Methods for Applying Accurate Digital PCR Analysis on Low Copy DNA Samples

(2013) Alexandra S. Whale et al.   PLoS One

Epidermal Growth Factor Receptor Mutation Status in Circulating Free DNA in Serum: From IPASS, a Phase III Study of Gefitinib or Carboplatin/Paclitaxel in Non-small Cell Lung Cancer

(2011) Koichi Goto et al.   Journal of Thoracic Oncology

Detection and Monitoring of Cell-Free DNA in Blood of Patients with Colorectal Cancer

(2009) Heidi Schwarzenbach et al.   Annals of the New York Academy of Sciences

Analysis of Circulating Tumor DNA to Confirm Somatic KRAS Mutations

(2009) Matthias Holdhoff et al.   JNCI-Journal of the National Cancer Institute